Deletion of Chromosomal Region 8p21 Confers Resistance to Bortezomib and Is Associated With Upregulated Decoy TRAIL Receptor Expression in Patients With Multiple Myeloma

PLoS ONE - United States
doi 10.1371/journal.pone.0138248
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

Surface TRAIL Decoy Receptor-4 Expression Is Correlated With TRAIL Resistance in McF7 Breast Cancer Cells

BMC Cancer
Cancer ResearchOncologyGenetics
2005English

Is Edentulism Associated With Lower Bacteremia and Transplant-Associated Toxicities in Patients With Multiple Myeloma?

Biology of Blood and Marrow Transplantation
TransplantationHematology
2013English

ACE Insertion/Deletion Polymorphism (Rs4646994) Is Associated With the Increased Risk of Multiple Myeloma

Frontiers in Oncology
Cancer ResearchOncology
2019English

High Sub-Clonal Fraction of 17p Deletion Is Associated With Poor Prognosis in Multiple Myeloma

Blood
BiochemistryImmunologyCell BiologyHematology
2019English

Phase 2 Trial of Ixazomib in Patients With Relapsed Multiple Myeloma Not Refractory to Bortezomib

Blood Cancer Journal
OncologyHematology
2015English

Oculomotor Nerve Palsy Associated With Bortezomib in a Patient With Multiple Myeloma: A Case Report

Journal of Medical Case Reports
Medicine
2010English

Bortezomib Induces Heme Oxygenase-1 Expression in Multiple Myeloma

Cell Cycle
MedicineDevelopmental BiologyCell BiologyMolecular Biology
2012English

MAFb Protein Confers Intrinsic Resistance to Proteasome Inhibitors in Multiple Myeloma

BMC Cancer
Cancer ResearchOncologyGenetics
2018English

Bortezomib for the Treatment of Multiple Myeloma Patients

Health Technology Assessment
MedicineHealth Policy
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy